All Stories

  1. Patient satisfaction with the management of refractory and unexplained chronic cough in Canada: Results from a national survey
  2. Gefapixant for Chronic Cough—Reply
  3. Acuity of asthma exacerbations in Alberta, Canada is increasing: a population-based study
  4. Impact of Chronic Cough on Quality of Life
  5. Burden of chronic cough on social participation, healthcare resource utilisation and activities of daily living in the Canadian Longitudinal Study on Aging (CLSA)
  6. The added value of haemoglobin to height, age, and sex to predict DLCO in subjects with preserved exercise capacity
  7. Protein expression of SARS‐CoV‐2 receptors ACE2 and TMPRSS2 in allergic airways after allergen challenge
  8. Emerging drugs in the treatment of chronic cough
  9. Performance of cough monitoring by Albus Home, a contactless and automated system for nocturnal respiratory monitoring at home
  10. The Role of Viral Infections on Severe Asthma Exacerbations: Present and Future
  11. Writing Your Paper from the Middle
  12. Impact of mental health and personality traits on the incidence of chronic cough in the Canadian Longitudinal Study on Aging
  13. Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD
  14. Language and Geographical Location influences the Incidence of Chronic Cough in the Canadian Longitudinal Study on Aging (CLSA)
  15. Assessing cough symptom severity in refractory or unexplained chronic cough: findings from patient focus groups and an international expert panel
  16. A Wearable Tele-Health System towards Monitoring COVID-19 and Chronic Diseases
  17. Is tezepelumab more than just an anti-eosinophil drug?
  18. Effect of centrally and peripherally acting GABAB agonism on the healthy human cough reflex
  19. Chronic cough: Investigations, management, current and future treatments
  20. Prevalence, incidence, and characteristics of chronic cough among adults from the canadian longitudinal study on ageing (CLSA)
  21. The impact of Beta Blockade on cardio-respiratory system and symptoms during exercise
  22. Breastfeeding and risk of childhood asthma: a systematic review and meta-analysis
  23. Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework
  24. Limosilactobacillus reuteri DSM‐17938 for preventing cough in adults with mild allergic asthma: A double‐blind randomized placebo‐controlled cross‐over study
  25. An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough
  26. Effects of cigarette smoke exposure on pulmonary physiology, muscle strength and exercise capacity in a retrospective cohort with 30,000 subjects
  27. Effect of anti‐IL‐5 biologics on weight and body mass index
  28. Is there clinical value in performing capsaicin cough challenges in patients with severe asthma?
  29. Prevalence, incidence and characteristics of chronic cough among adults from the Canadian Longitudinal Study on Aging
  30. A Randomized Controlled Trial to Assess the Effect of Lidocaine Administered via Throat Spray and Nebulization in Patients with Refractory Chronic Cough
  31. Influence of age, sex and respiratory viruses on the rates of emergency department visits and hospitalisations with respiratory tract infections, asthma and COPD
  32. Reply to: Noxious cold stimulation: pro–con perspectives on the hypothermic effect on experimentally evoked cough
  33. Prognostic factors associated with small for gestational age babies in a tertiary care hospital of Western Nepal: A cross‐sectional study
  34. Exercise Induced Bronchoconstriction and Bronchodilation; investigating the effects of age, sex, airflow limitation and the FEV1
  35. The Impact of beta blockade on the cardio-respiratory system and symptoms during exercise
  36. Emergency department visits and hospitalisations for asthma, COPD and respiratory tract infections: what is the role of respiratory viruses, and return to school in September, January and March?
  37. Identifying a Neurophenotype in Severe Asthma
  38. Tracheobronchomegaly, cough and recurrent chest infection: Mounier-Kuhn syndrome
  39. The contribution of FEV 1 and airflow limitation on the intensity of dyspnea and leg effort during exercise. Insights from a real‐world cohort
  40. Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma
  41. Falsely Accused? Insufficient Evidence to Conclude that Sitagliptin is a Cause of Chronic Cough
  42. The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough
  43. Allergen challenge increases capsaicin-evoked cough responses in patients with allergic asthma
  44. Cough rhythms in asthma: Potential implication for management
  45. Investigating the safety of capsaicin cough challenge in severe asthma
  46. Under- and over-diagnosis of COPD: a global perspective
  47. Oxygen therapy for acutely ill medical patients: a clinical practice guideline
  48. Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018
  49. Research highlights from the 2017 ERS International Congress: airway diseases in focus
  50. XEN-D0501, a Novel Transient Receptor Potential Vanilloid 1 Antagonist, Does Not Reduce Cough in Patients with Refractory Cough
  51. Airways diseases: insights from the European Respiratory Society Annual Congress 2017
  52. Chronic cough: Are we integrating non-pharmacological therapies into treatment plans?
  53. Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough
  54. Capsaicin-evoked cough responses in asthmatic patients: Evidence for airway neuronal dysfunction
  55. The interaction between bronchoconstriction and cough in asthma
  56. Towards understanding and managing chronic cough
  57. Investigating the interaction between bronchoconstriction and cough in asthma
  58. Objective Cough Frequency, Airway Inflammation, and Disease Control in Asthma
  59. Investigating Neuronal responses by assessing Cough in Asthma
  60. Correction
  61. Assessing the accuracy and certainty in interpreting chest X-rays in the medical division
  62. Not your typical pneumonia
  63. Not your typical pneumonia
  64. IMPROVING THE MANAGEMENT OF HOSPITAL ACQUIRED PNEUMONIA (HAP)
  65. AUDIT ON PLEURAL PROCEDURE IN A UK DISTRICT GENERAL HOSPITAL
  66. HEALTHY HOSPITALS PROJECT: SMOKING HABITS AND CESSATION ADVICE IN HOSPITAL
  67. The importance of being earnest; in haemostasis after femoral venepuncture
  68. Acute disc prolapse secondary to seizure
  69. P0078 A CASE PRESENTATION OF HEPATIC SARCOID